Transplant vs CAR T-Cell Therapy

This page is for people with a blood cancer who are weighing a stem cell transplant against CAR T-cell therapy. Both may come up in cancer care. Neither is simply "better" or "worse." They differ in goals, evidence, side effects, logistics, and backup plans.

A blood or marrow stem cell transplant can replace blood-forming cells after intensive treatment. It can also use donor immune cells to act against the cancer.

Ask what problem the option is meant to solve. It may be shrinking the cancer, lowering the risk that it comes back, controlling symptoms, or buying time for another treatment.

CAR T-cell therapy re-engineers a person's own T cells (a type of immune cell) to recognize a target on cancer cells. It is used in selected leukemias, lymphomas, and myeloma, and in clinical trials.

The best comparison is personal. Age alone rarely decides. Doctors also weigh your test results, past treatment, organ function, support at home, travel distance, and your own goals.

Many things shape this decision. They include timing, past treatments, whether a donor is available, and the target on the cancer cells. Infection risk, the chance of relapse, and how far you must travel also matter.

Ask the same questions about both options. What is the expected benefit? Which side effects are common? Which side effects may be permanent? How soon would treatment start? How long would recovery take? What monitoring follows?

• What would your specialty's treatment try to accomplish for me?
• What would make you recommend the other option instead?
• What outcomes matter most for someone like me?
• What side effects would change daily life?
• Would treatment order matter?
• Is there a clinical trial comparing these approaches?

Ask for a second opinion when:

• The decision affects fertility, work, or daily function.
• Another treatment center offers a different approach.
• One team says there is only one reasonable option, but you are not sure why.

Both treatments lower your defenses against infection. CAR T-cell therapy can also cause cytokine release syndrome, an overreaction of the immune system that brings very high fever and a sharp drop in blood pressure. It can cause nerve effects too.

• Call 911 or go to an emergency department if you feel faint or cannot stay awake, get confused, cannot speak clearly, have a seizure, or struggle to breathe. Do not drive yourself.
• Call your transplant or CAR T team at once, at any hour, if you have a temperature of 100.4°F (38°C) or higher, or shaking chills. After either treatment your infection defenses are down, and the CDC calls a fever during chemotherapy a medical emergency. If you cannot reach them quickly, go to an emergency department and say on arrival which treatment you have had.
• Call your transplant or CAR T team right away, day or night, if you notice new redness, swelling, or pain where a line enters your body, or you have a new cough, sore throat, diarrhea, mouth sores or white coating, or a rash. NCI lists these among infection signs, and your defenses are low.

Ask your team for the after-hours number before treatment starts. Talk with your team before taking any fever medicine, even acetaminophen or ibuprofen.

Start with Cancer Treatment Overview, Questions to Ask Your Oncologist, Clinical Trial vs Standard Treatment, and Getting a Second Opinion.

• National Cancer Institute — Stem Cell and Bone Marrow Transplants for Cancer
• National Cancer Institute — CAR T Cells: Engineering Immune Cells to Treat Cancer
• National Cancer Institute — Infection and Neutropenia During Cancer Treatment
• CDC — Fever and Cancer Treatment